Editors' ChoicePharmacology

Paper of note in Science Translational Medicine 9 (373)

See allHide authors and affiliations

Sci. Signal.  24 Jan 2017:
Vol. 10, Issue 463, eaam8057
DOI: 10.1126/scisignal.aam8057

This week’s paper describes a drug that inhibits multiple growth factor pathways and may effectively treat patients with retinopathies.

RETINOPATHY

A better drug for diseases of the retina

An integrin-binding peptide derived from collagen IV prevents ligand-induced activation of multiple tyrosine kinase receptors and strongly suppresses ocular neovascularization and vascular leakage.

Highlighted Article

View Abstract

Navigate This Article